Inflammatory Bowel Disease and Interleukin-17 Inhibitors in Hidradenitis Suppurativa

Study limitation reported by the research below: “Specific IL-17 inhibitors studied are not named in the abstract; individual drug-level safety signals cannot be distinguished from this summary alone.”